Strides Pharma Science Ltd Quarterly Results
Q2 FY26-27 Results Summary
Revenue
The revenue stands at ₹1,429.73 crore, reflecting a quarter-on-quarter *(QoQ) increase of 12.99 per cent from ₹1,265.41 crore. This corresponds to a year-on-year *(YoY) growth of 17.11 per cent.
Operating Profit
Operating Profit stands at ₹249.21 crore, reflecting a quarter-on-quarter *(QoQ) increase of 9.07 per cent from ₹228.49 crore. This corresponds to a year-on-year *(YoY) growth of 12.38 per cent.
PBDT
PBDT stands at ₹207.66 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 18.89 per cent from ₹256.02 crore. This corresponds to a year-on-year *(YoY) growth of 2.42 per cent.
Profit Before Tax
Profit Before Tax stands at ₹150.44 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 24.64 per cent from ₹199.62 crore. This corresponds to a year-on-year *(YoY) decline of 1.74 per cent.
Net Profit
Net Profit stands at ₹134.12 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 18.96 per cent from ₹165.49 crore. This represents a 1.98 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Strides Pharma Science Ltd News
Strides Pharma Science Ltd Earnings
- YOY
- QOQ
Strides Pharma Science Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Strides Pharma Science Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Strides Pharma Science Ltd Financial Reports
Strides Pharma Science Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Strides Pharma | -2.67% | 3.65% | -1.54% | 4.02% | 3.66% | 8.63% |
| Corona Remedies | -3.11% | 5.20% | 5.37% | 1.94% | 23.96% | 49.32% |
| Concord Biotech | 1.16% | -4.67% | -8.07% | -11.84% | 4.20% | -15.18% |
| Akums Drugs | -1.07% | 6.75% | -8.58% | 7.55% | 30.87% | 56.31% |
| Viyash Scientific | -2.63% | 5.30% | -4.69% | -17.19% | 6.77% | 0.25% |
| Blue Jet Health | 0.17% | 4.03% | -4.98% | -14.42% | 5.89% | -25.25% |
| P & G Health Ltd | 3.29% | 12.47% | 7.22% | -12.42% | 10.37% | -6.65% |
Company Info
Company Information
Chairman & Non Executive Dir. : Arun Kumar
Group CEO & Executive Director : Badree Komandur
Executive Director & COO : VENKATA SEETHARAMA RAJU PAKALAPATI
Independent Non Exe. Director : Kausalya Santhanam
Independent Non Exe. Director : Mukta Malik Arora
Independent Non Exe. Director : Subir Chakraborty
Independent Non Exe. Director : Homi R Khusrokhan
Independent Non Exe. Director : Ameet Hariani
Company Sec. & Compli. Officer : Manjula Ramamurthy
Independent Director : Biren Gabhawala